Welcome to the OMA Blog
The Obesity Medicine Association Blog is the leading industry hub for obesity medicine. Find the latest research, expert insights, and practical tips to tackle the multifaceted disease of obesity. Hear from OMA Outreach Committee members, OMA Board members, and more to gain a deeper understanding of the complex factors influencing obesity and explore innovative approaches to prevention, treatment, and long-term management. Join a community of healthcare professionals, researchers, and individuals passionate about combating obesity.
View by Category
Obesity Medicine Association Raises Concerns Over Lancet Commission’s New Recommendations on Obesity Diagnosis
January 27, 2025 – The Obesity Medicine Association (OMA) acknowledges the Lancet Commission’s effort to refine obesity diagnosis with the introduction of “preclinical” and “clinical” obesity classifications. However, we express significant concerns about the potential unintended consequences of this framework, which risks redefining obesity from a disease to merely a risk factor, undermining decades of progress in recognizing obesity as a chronic, progressive and relapsing multifactorial disease.
Celebrating 75 Years: A Journey Through the History of the Obesity Medicine Association
Explore the milestones, innovations, and advocacy efforts that have shaped the field, from early beginnings to modern breakthroughs. Join us in honoring the past and advancing the future of obesity medicine.
Pediatric Research Update: Food as Medicine for Obesity Treatment and Management
This article explores dietary interventions for obesity, emphasizing personalized nutrition plans, evidence-based culinary medicine, and sustainable diets like Mediterranean and DASH. It highlights calorie reduction, meal timing, and weight maintenance strategies.
Obesity and Exercise
Explore the relationship between obesity and exercise, including current guidelines, challenges, and benefits beyond weight loss.
Pediatric Research Update: The Risk of Depression, Anxiety, and Suicidal Behavior in Patients With Obesity on Glucagon Like Peptide-1 Therapy
Risk of major depression, anxiety, and suicidal ideation or attempts were increased in adults who took glucagon like peptide-1 receptor agonist medication for type 2 diabetes or obesity compared with propensity score matched adults with obesity who did not take this medication.
The Vegan Diet and Weight Loss
In the U.S., only about 1% of people follow a strictly vegan diet, according to a 2023 Gallup poll. However, many others say they have considered or tried it or are at least trending away from animal-based foods.
Sarcopenic Obesity: Causes, Diagnosis & Treatment
Explore the emerging health issue of sarcopenic obesity and its impact on aging populations in our comprehensive guide.
Obesity and Insulin Resistance: Symptoms, Diagnosis, and Treatment
Explore the link between obesity and insulin resistance. Understand the risk factors, symptoms, and treatments for this dual health challenge.
Pediatric Research Update: Changes in Objectively Measured Sleep After a Multidisciplinary Lifestyle Intervention in Children with Abdominal Obesity: A Randomized Trial
Adequate and good quality sleep is essential for optimal health and plays a key role in managing obesity and metabolic disorders. A recent study demonstrates that lifestyle interventions for obesity can significantly improve sleep quality, reinforcing the interconnection between sleep and weight management.